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Abstract
Aims/hypothesis Enterovirus infections have been associated
with the development of type 1 diabetes in multiple studies,
but little is known about enterovirus-induced responses in
children at risk for developing type 1 diabetes. Our aim was
to use genome-wide transcriptomics data to characterise
enterovirus-associated changes in whole-blood samples from
children with genetic susceptibility to type 1 diabetes.
Methods Longitudinal whole-blood samples (356 samples in
total) collected from 28 pairs of children at increased risk for
developing type 1 diabetes were screened for the presence of
enterovirus RNA. Seven of these samples were detected as
enterovirus-positive, each of them collected from a different
child, and transcriptomics data from these children were
analysed to understand the individual-level responses associ-
ated with enterovirus infections. Transcript clusters with
peaking or dropping expression at the time of enterovirus
positivity were selected as the enterovirus-associated signals.
Results Strong signs of activation of an interferon response
were detected in four children at enterovirus positivity, while
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transcriptomic changes in the other three children indicated
activation of adaptive immune responses. Additionally, a large
proportion of the enterovirus-associated changes were specific
to individuals. An enterovirus-induced signature was built
using 339 genes peaking at enterovirus positivity in four of
the children, and 77 of these genes were also upregulated in
human peripheral blood mononuclear cells infected in vitro
with different enteroviruses. These genes separated the four
enterovirus-positive samples clearly from the remaining 352
blood samples analysed.
Conclusions/interpretation We have, for the first time, identi-
fied enterovirus-associated transcriptomic profiles in whole-
blood samples from children with genetic susceptibility to
type 1 diabetes. Our results provide a starting point for under-
standing the individual responses to enterovirus infections in
blood and their potential connection to the development of
type 1 diabetes.
Data availability The datasets analysed during the current
study are included in this published article and its supple-
mentary informat ion fi les (www.btk. f i / research/
computational-biomedicine/1234-2) or are available from
the Gene Expression Omnibus (GEO) repository (accession
GSE30211).
Keywords Clinical immunology . Enterovirus . Human .
Microarray . Prediction and prevention of type 1 diabetes
Abbreviations
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Introduction
Enteroviruses are among the most common viruses causing
infections in humans. They are single-stranded RNA viruses
that replicate typically in the intestine, but can occasionally
spread also to blood and certain internal organs. Although
enterovirus infections are mostly asymptomatic or cause only
mild symptoms, they can also cause severe illnesses such as
meningitis, myocarditis and hand-foot-and-mouth disease.
Several studies have associated viral infections, especially
human enterovirus infections, with the development of type 1
diabetes [1–4]. Enteroviruses have a clear tropism to pancre-
atic beta cells [5], and low-grade enterovirus infection has
been detected in pancreatic islets of living individuals with
recently diagnosed type 1 diabetes [6]. Prospective studies
have also found signs of enterovirus infectionsmore common-
ly in children who later develop type 1 diabetes autoantibodies
or clinical type 1 diabetes than in control children [1, 2, 7].
The presence of enteroviruses is not, however, thought to di-
rectly result in an increased risk of type 1 diabetes. The out-
comes of infection likely depend on complex relationships
between the host and the virus: for example, the genetic back-
ground and individual properties of the host [8–11], the timing
of infections [12] and the type of enterovirus invading the host
[13, 14]. Currently, only limited data are available regarding
in vivo enterovirus responses in children at risk for developing
type 1 diabetes, and most studies still rely on in vitro infection
models. Therefore, better understanding of the individual-
level responses to enterovirus infection is required to gain
insights into the variable outcomes of these infections.
In this study, we performed, for the first time, genome-wide
transcriptomic analysis of enterovirus-associated changes in
children with genetic susceptibility to type 1 diabetes. We
analysed microarray data from 44 longitudinally collected
whole-blood samples [15] from seven children who were
enterovirus-positive in one of the follow-up samples. Our
aim was to understand the individual-level transcriptomic
changes associated with enterovirus infections and to charac-
terise the common features of enterovirus responses in young
children.
Methods
Study participants and sample selection The microarray
data used in this study are part of the dataset published by
Kallionpää et al [15] (GEO accession GSE30211) covering
356 PAXGene whole-blood RNA samples measured using
the Affymetrix Human Genome U219 Array (Affymetrix,
Santa Clara, CA, USA). The samples were collected from
28 pairs of children participating in the Finnish Type 1
Diabetes Prediction and Prevention (DIPP) study in Turku,
Finland. All children in the DIPP study carry HLA-
conferred genetic risk for type 1 diabetes, and they have been
observed from birth at regular intervals [16]. All children had
written parental consent and the Ethics Committee of Turku
University Hospital had granted approval for the DIPP study.
The study was carried out in accordance with the principles of
the Declaration of Helsinki.
The presence of enterovirus RNAwas studied using quanti-
tative RT-PCR as described previously [17] from the same 356
RNA samples used for the microarray analyses. The RT-PCR
was carried out in three parallel reactions. If all three reactions
gave a positive result, the sample was classified as strongly
enterovirus-positive; if only one of the reactions was positive,
the samplewas classified asweakly enterovirus-positive. In total,
seven samples were detected as enterovirus-positive, each
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collected from a different child. Microarray data of all 44 sam-
ples from these enterovirus-positive children were selected for
further analyses (electronic supplementary material [ESM]
Table 1).
Microarray data processing and clustering The microarray
data were pre-processed using the robust multiarray average
(RMA) method implemented in the Bioconductor package
affy version 1.44.0 (http://bioconductor.org/packages/release/
bioc/html/affy.html), and log2-transformed. The Universal
exPression Codes (UPC) method of the Bioconductor pack-
age SCAN.UPC version 2.12.1 (https://bioconductor.org/
packages/release/bioc/html/SCAN.UPC.html) [18] was used
to filter out probe sets with low expression (UPC < 0.5 in all
the samples).
For each probe set, the RMA-normalised expression values
were transformed into z scores based on their child-specificmean
and standard deviation over the virus-negative samples. The
z score profiles were clustered separately for each child using
the k-means algorithm, with Pearson correlation and k = 10. For
each child, the clusters with the highest and lowest centroid
values at the time of enterovirus positivity were identified
(referred to as peaking and dropping clusters, respectively).
Functional data analysis Functional classification of the data
was performed using the Database for Annotation, Visualization
and Integrated Discovery (DAVID; https://david.ncifcrf.gov/;
accessed November to December 2016) [19] and Ingenuity
Pathway Analysis (IPA; Qiagen Bioinformatics, Aarhus,
Denmark, www.qiagenbioinformatics.com/products/ingenuity-
pathway-analysis/; accessed November to December 2016)
tools. Gene ontology classes with DAVID false-discovery rate
(FDR) < 0.05 and IPA pathways with p value < 0.001 were
considered significantly enriched. The Interferome 2.01 database
(www.interferome.org; accessed November to December 2016)
[20] was used to study the presence of human interferon-
regulated genes.
Microarray data from human PBMCs infected in vitro
The transcriptomics data from children at risk for type 1 diabe-
tes were compared with microarray data (HumanHT-12 V3.0
BeadChip, Illumina, San Diego, CA, USA) from peripheral
blood mononuclear cells (PBMCs) infected with enterovirus
in vitro [14], including three replicate samples of PBMCs in-
fected with ATCC strain of echovirus 9 or wild-type Coxsackie
B1 virus strains CDC10802 and CDC10796 for 48 h, and
uninfected control PBMCs (see Dataset 1 published on
https://www.btk.fi/1234-2/). The data were pre-processed using
the variance-stabilising normalisation of the Bioconductor lumi
package version 2.18.0 (https://bioconductor.org/packages/
release/bioc/html/lumi.html) [21]. The UPC method was used
to filter out probes with low expression until reaching the
number of probes equal to the dataset from the enterovirus-
positive children. Differential expression was determined using
the Bioconductor ROTS [22] package version 1.1.1 (https://
bioconductor.org/packages/release/bioc/html/ROTS.html) and
cut-off values FDR < 0.05 and fold change > 1.5. To enable
comparison between the Illumina and Affymetrix platforms,
the probes and probe sets were mapped to genes using IPA
(Qiagen; accessed November to December 2016).
Results
Enterovirus RNA was detected in seven of 356 whole-blood
RNA samples, with five strongly enterovirus-positive and two
weakly enterovirus-positive samples each taken from a differ-
ent child.
To characterise enterovirus-associated changes in whole-
blood transcriptome, we studied longitudinal gene expression
profiles of these enterovirus-positive children by dividing all
probe sets child-specifically into ten clusters (ESM Fig. 1; see
also Dataset 2 published on https://www.btk.fi/1234-2/). For
each child, the clusters with the highest and lowest centroid
value at the time of enterovirus positivity were selected as the
enterovirus-associated signals (Fig. 1a–g).
For four strongly enterovirus-positive children, the overlaps
between peaking and dropping clusters were higher (average
overlaps of 46% and 37%, respectively) than those between the
other children (average overlaps of 8%) (Fig. 1h, i). In total,
593 probe sets mapping to 339 distinct genes were detected in
the peaking clusters of all four children. This set was defined as
the enterovirus-induced signature. However, approximately
20% of the probe sets in each of these peaking clusters were
child-specific, indicating the presence of individual differences
in enterovirus responses. The other three children had lower
overlaps with each other and with all other children.
Genes involved in antiviral immune responses and espe-
cially interferon signalling were significantly enriched in both
the peaking clusters of the four strongly enterovirus-positive
children and the enterovirus-induced signature (Fig. 2a; see
also Dataset 2 published on https://www.btk.fi/1234-2/). Also,
child-specific expression profiles of two interferon signalling
genes, STAT2 and MX1, showed clear peaks in the four chil-
dren at enterovirus positivity (Fig. 2b–h). Furthermore, 74%
of the signature genes were regulated by interferons based on
the Interferome database. The B cell receptor signalling path-
way was among the most significantly enriched pathways in
the peaking clusters of the other three children, potentially
reflecting the activation of adaptive immune responses.
Based on the dropping clusters, enterovirus infection was also
associated with downregulation of genes involved in mRNA
processing, transcription or translation in six of the seven chil-
dren (see Dataset 3 published on https://www.btk.fi/1234-2/).
Enterovirus RNA is detectable in blood for only a few days
during the acute phase of infection. To estimate the timing of
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infection relative to sample collection, we compared our peaking
and dropping clusters with whole-blood transcriptional changes
during acute and recovery phases after influenza virus infection,
as reported by Zhai et al [23] (see Dataset 2 published on https://
www.btk.fi/1234-2/). Of the 25 top genes upregulated during the
acute phase of influenza infection [23], 23 overlapped our
enterovirus-induced signature. Also, all seven natural killer
(NK) cell activation signature genes associated with the acute
phase of influenza infection [23] peaked in more than one of the
enterovirus-positive children. Overlaps with the top up- and
downregulated genes specific for the recovery phase after influ-
enza virus infection [23] were low for all the children.
We also compared our results with enterovirus-induced
responses in human PBMCs infected in vitro with three differ-
ent enteroviruses [14]. The genes upregulated in the in vitro
infections were enriched with those associated with the defence
response to virus and the type I interferon signalling pathway,
similarly to the genes in our enterovirus-induced signature. Of
the genes upregulated by any of the enteroviruses, 70% were
present in at least one of the peaking clusters. Overall, 77 genes
present in the enterovirus-induced signature were upregulated
in all three in vitro infections (ESM Fig. 2a). Of these genes, 73
were interferon-regulated based on the Interferome database.
Although only approximately 50% of the genes downregulated
in the in vitro infections were present in any of the dropping
clusters of enterovirus-positive children, genes associated with
translation were enriched in both datasets.
As enteroviruses are known to infect pancreatic islets [5]
and have been found in pancreases of individuals with type 1
diabetes more often than in non-diabetic control groups [24,
25], we also compared our results with enterovirus-induced
responses in human pancreatic islets infected in vitro with en-
teroviruses [10, 26]. Approximately half of the enterovirus-
induced genes in human pancreatic islets [10, 26] were also
present in our enterovirus-induced blood transcriptomic signa-
ture in children at risk for developing type 1 diabetes (ESM
Fig. 2b), while the overlaps with the genes present in the
peaking clusters of the other three type 1 diabetes risk children
were low (ESM Fig. 2b). In total, there were 64 enterovirus-
induced genes common to the in vitro infected pancreatic islets
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Fig. 1 (a–g) Average expression profiles of clusters peaking or dropping
at enterovirus positivity for the seven enterovirus-positive children:
Strong 1 (a), Strong 2 (b), Strong 3 (c), Strong 4 (d), Strong 5 (e),
Weak 1 (f) andWeak 2 (g). Red, peaking clusters; blue, dropping clusters.
EV+, enterovirus-positive. (h, i) Overlapping probe sets between the
peaking and dropping clusters. The black areas indicate the proportion
of overlapping probe sets relative to the child/cluster noted at the top of
the column. The boxes highlighted in the outlined frame show the
peaking (h) and dropping (i) clusters of the four strongly enterovirus-
positive children with the most similar enterovirus-associated changes.
The total numbers of probe sets in each cluster are presented in the
diagonal. The five children with strongly enterovirus-positive blood
samples are denoted as Strong 1–Strong 5. The two children with weakly
enterovirus-positive blood samples are denoted as Weak 1 and Weak 2
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[10, 26] and our enterovirus-induced blood transcriptomic sig-
nature, all of which were associated with antiviral interferon
responses, including IFIH1, IRF7, MX1, STAT1 and STAT2.
Finally, we tested whether the 339 enterovirus-induced sig-
nature genes or the 77 genes also upregulated in all three
in vitro infections of human PBMCs could differentiate be-
tween the enterovirus-positive and enterovirus-negative blood
samples in the full transcriptomics dataset by Kallionpää et al
[15]. The four enterovirus-positive samples with clear signs of
interferon response activation were clearly separated from all
other samples using either of the gene sets, while the other three
enterovirus-positive samples were not separated from the
enterovirus-negative samples (Fig. 3a, ESM Fig. 3a). To ensure
that the observed separation was not due to the use of the same
four enterovirus-positive children in defining the signature, a
similar analysis was performed using the genes upregulated in
the in vitro infected PBMCs by any of the three enteroviruses.
Here also, the four strongly enterovirus-positive samples were
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Fig. 2 (a) Genes in peaking clusters mapping to the interferon signalling
pathway based on the IPA tool. Red, genes present in at least four peaking
clusters of the strongly enterovirus-positive children; pink, genes present
in at least one peaking cluster. (b–h) Child-specific expression profiles of
two genes of the interferon signalling pathway, MX1 (grey) and STAT2
(black). IFNγ is also known as IFNG; IFNα/β is also known as IFNA1/
B1; TC-PTP is also known as PTPN2; NF-κB p65 is also known as
RELA; BCL-2 is also known as BCL2; BAK is also known as BAK1;
DRIP150 is also known as MED14; G1P2 is also known as ISG15;
G1P3 is also known as IFI6. EV+, enterovirus-positive; GAS, IFNG-
activated sequence; ISRE, interferon-stimulated regulatory element. The
five children with strongly enterovirus-positive blood samples are denot-
ed as Strong 1–Strong 5 (b–f). The two children with weakly enterovirus-
positive blood samples are denoted as Weak 1 and Weak 2 (g, h)
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clearly separated from the enterovirus-negative samples (ESM
Fig. 3b).
Upregulation of interferon-regulated genes during entero-
virus infection is one of the conspicuous features in this study,
and activation of interferon signalling has been observed in
the blood of children who have developed diabetes-related
autoantibodies or clinical type 1 diabetes before the first de-
tection of autoantibodies [15, 27]. However, the expression of
the 339 enterovirus-induced signature genes (ESM Figs 3a, c
and 4) or the 77 genes also upregulated with in vitro entero-
virus infection (Fig. 3a, b) did not show marked differences
between autoantibody-negative and autoantibody-positive
children before or after seroconversion based on the longitu-
dinal blood transcriptomics data from children at risk for type
1 diabetes reported by Kallionpää et al [15] or Ferreira et al
[27]. Moreover, fewer than 50% of the genes upregulated in
children who have developed diabetes-related autoantibodies
or clinical type 1 diabetes in the two aforementioned studies
[15, 27] overlapped with the enterovirus-induced signature
(Fig. 3c, ESM Fig. 3c).
Discussion
In the current study, we have identified enterovirus-associated
transcriptomic profiles in whole-blood samples from seven chil-
dren with genetic susceptibility to type 1 diabetes and
characterised their individual responses to enterovirus infections.
Interferon response is a central part of the innate antiviral
immune response, and several enterovirus strains induce a
profound interferon response in human blood cells [14, 28].
We detected clear signs of interferon response activation in
four strongly enterovirus-positive children. Enterovirus-
associated changes in these children resembled previously re-
ported differences occurring during the acute phase of virus
infection [23], indicating that these samples were collected
during the acute phase of infection characterised by high virus
load. In two children with only weakly enterovirus-positive
blood samples and one child with a strongly enterovirus-
positive blood sample, no strong signs of interferon response
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Fig. 3 Expression of the 77 genes present in our enterovirus-induced
signature and upregulated in all three in vitro enterovirus infections in
microarray data published by: (a) Kallionpää et al [15]; and (b) Ferreira
et al [27]. Sums of child-specific z scores over the 77 genes were
calculated for each of the 356 whole blood samples by Kallionpää et al
[15] (GEO: GSE30211) and the 454 PBMC samples by Ferreira et al [27]
(Array Express: E-MTAB-1724), as described in Methods, using the
published pre-processed datasets and sample information based on
personal communications with Ferreira et al. All probes (a) or the
highest-intensity exons mapping to genes (b) overlapping with the 77
genes were summed. (a) Black, strongly enterovirus-positive blood
samples; white, weakly enterovirus-positive blood samples; grey,
enterovirus-negative blood samples. (a, b) PreSero, samples collected
from before seroconversion from children with autoantibody positivity
or type 1 diabetes (in a, n = 22; in b, n = 65); PostSero, samples collected
after seroconversion from children with autoantibody positivity or type 1
diabetes (in a, n = 169; b n = 84), Aab−, samples collected from
autoantibody-negative children (in a, n = 165; in b, n = 305). (c) Venn
diagram showing the overlaps between the 77 genes present in the
enterovirus-induced signature and upregulated in all three in vitro
enterovirus infections; genes upregulated before or after seroconversion
in autoantibody-positive children based on the results by Kallionpää et al
[15] and the 225 interferon-inducible genes detected by Ferreira et al [27]
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were detected, but changes implying the activation of adaptive
immune responses were observed. Enterovirus-associated
downregulation of transcription, translation or mRNA
processing-associated genes was observed in six children, al-
though the individual probes and genes mapping to these cat-
egories varied between individuals. Upregulation of interferon
response genes and downregulation of translation-associated
genes were also detected in human PBMCs infected in vitro
with three different enteroviruses. Finally, upregulation of
genes associated with interferon responses was the common
feature between enterovirus-induced blood transcriptomic
changes in four children at risk for developing type 1 diabetes
and in vitro enterovirus-infected human pancreatic islets [10,
26], creating a link between the virus–host interplay in blood
and in the pancreas.
We built an enterovirus-induced signature covering 339
genes present in the peaking clusters of the four children with
clear indications of interferon response activation, and a more
selective signature of 77 genes additionally upregulated in
human PBMCs infected in vitro with three different enterovi-
ruses. Both signatures separated the four strongly enterovirus-
positive samples from the other samples in the full microarray
dataset published by Kallionpää et al [15].
The enterovirus-associated signature showed only moder-
ate overlap with the upregulated genes in Kallionpää et al [15]
and Ferreira et al [27], and could not differentiate between
children who developed type 1 diabetes autoantibodies or
clinical type 1 diabetes and autoantibody-negative children
in those studies (ESM Fig. 3). Although activation of interfer-
on signalling has been shown to precede the development of
autoimmunity in children at risk for type 1 diabetes, our results
indicate differences between enterovirus-associated and type
1 diabetes-associated interferon signals.
The four children with clear signs of interferon response
activation included two persistently autoantibody-negative
children, one child who later became positive for multiple type
1 diabetes autoantibodies and one autoantibody-positive child
who later developed clinical type 1 diabetes. With the limited
number of children available for the current study, and the
significant amount of heterogeneity in enterovirus-associated
changes between the children, it is not possible to draw con-
clusions regarding connections between enterovirus infections
and type 1 diabetes.
There are several factors that can explain the observed
heterogeneity in the enterovirus-associated responses. First,
earlier in vitro studies have shown that the magnitude of
interferon response induction in PBMCs varies significantly
between different enteroviruses [14]. Second, the rapid kinet-
ics of antiviral immune responses can be a source of signifi-
cant heterogeneity when characterising enterovirus-associated
blood transcriptomic changes in follow-up studies with long
sampling intervals, although enterovirus RNA can be detected
in blood for only a few days during the acute phase of
infection. Third, host responses to acute infections caused by
different viruses can be similar, and sometimes the diver-
gences between viruses are better explained by the different
magnitudes of the effect than by the actual genes responding
to infection [23, 29]. Although our enterovirus-induced signa-
ture has a high overlap with in vitro enterovirus-induced
changes in human PBMCs and pancreatic islets, we cannot
conclude that these changes are uniquely observed after infec-
tion with enteroviruses. Finally, although enterovirus infec-
tions are often asymptomatic, clinical symptoms were report-
ed for five of the seven children less than a week before the
collection of the enterovirus-positive blood samples. Three
children were suffering from fever around the time of
enterovirus-positive sample collection, including one child
also suffering from conjunctivitis, and common cold-like
symptoms were reported for two children. Interestingly, the
three children with fever around the time of enterovirus-
positive sample collection were strongly enterovirus-positive
based on quantitative RT-PCR and had clear signs of interfer-
on response activation associated with the enterovirus-
positive blood sample.
Despite the limitations of the current study, it provides a
starting point for understanding the individual responses to
enterovirus infections in vivo, and how these responses are
reflected in the mRNA expression profiles in whole blood.
Further longitudinal studies with larger cohorts, shorter sam-
pling intervals and better knowledge of the actual virus strains
infecting the individuals will provide deeper insights into the
associations between enterovirus infections and type 1
diabetes.
Acknowledgements The authors are grateful to the DIPP families for
their participation and the staff of the DIPP study for working with the
families and obtaining the samples for the study. We thank O. Simell, the
honorary principal investigator of the DIPP study, for his work. We also
thank R.C. Ferreira (University of Cambridge, Cambridge, UK) and
co-authors for sharing additional metadata of their samples (E-MTAB-
1724 [27]) with us.
Data availability The datasets analysed during the current study are
included in this published article and its supplementary information files
(www.btk.fi/research/computational-biomedicine/1234-2) or are
available from the GEO repository (accession GSE30211).
Funding This work was financially supported by the European
Research Council (ERC) (decision number 677943), JDRF (grants 17-
2013-533 and 2-2013-32), the Academy of Finland (Centre of Excellence
in Molecular Systems Immunology and Physiology Research, 2012–
2017, decision number 250114 and grants 287423, 288671, 292482,
292335, 294337, 296801 and 304995), the European Union’s Horizon
2020 research and innovation programme (decision number 675395),
Tekes, the Finnish Funding Agency for Innovation (1877/31/2016), the
Sigrid Jusélius Foundation, the Yrjö Johansson Foundation, the Finnish
Diabetes Research Foundation, the Reino Lahtikari Foundation, the
European Commission (Persistent Virus Infection in Diabetes Network
Diabetologia (2018) 61:381–388 387
[PEVNET] Frame Programme 7, contract number 261441) and the Paulo
Foundation.
Duality of interest The authors declare that there is no duality of inter-
est associated with this manuscript.
Contribution statement LTTA and LLE planned the data analyses.
LTTAwas responsible for analysing the data and participated in writing
the manuscript and preparing the figures. NL participated in planning the
data analyses, interpreted the results and participated in writing the man-
uscript and preparing the figures. HK participated in planning the data
analyses and interpreting the results. MKJ participated in analysing the
data and preparing the figures. JM, JT, JI, MK and RV provided and
interpreted the clinical information for the study children. HH and SO
were responsible for the virus analysis within the study, provided the
in vitro infection data and contributed to the initiation and design of the
study. RL and LLE initiated and designed the study, supervised the study
and participated in interpretation of the results andwriting themanuscript.
All authors edited/revised and approved the final version of the manu-
script. LLE is the guarantor of this work.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. Yeung WC, Rawlinson WD, Craig ME (2011) Enterovirus infec-
tion and type 1 diabetes mellitus: systematic review and meta-
analysis of observational molecular studies. BMJ 342:d35
2. Laitinen OH, Honkanen H, Pakkanen O et al (2014) Coxsackievirus
B1 is associated with induction of beta-cell autoimmunity that por-
tends type 1 diabetes. Diabetes 63:446–455
3. Beyerlein A, Donnachie E, Jergens S, Ziegler AG (2016) Infections in
early life and development of type 1 diabetes. JAMA 315:1899–1901
4. Hyoty H (2016) Viruses in type 1 diabetes. Pediatr Diabetes
17(Suppl 22):56–64
5. Ylipaasto P, Klingel K, Lindberg AM et al (2004) Enterovirus in-
fection in human pancreatic islet cells, islet tropism in vivo and
receptor involvement in cultured islet beta cells. Diabetologia 47:
225–239
6. Krogvold L, Edwin B, Buanes T et al (2015) Detection of a low-
grade enteroviral infection in the islets of Langerhans of living pa-
tients newly diagnosed with type 1 diabetes. Diabetes 64:1682–1687
7. Honkanen H, Oikarinen S, Nurminen N et al (2017) Detection of
enteroviruses in stools precedes islet autoimmunity by several
months: Possible evidence for slowly operating mechanisms in
virus-induced autoimmunity. Diabetologia 60:424–431
8. Santin I, Eizirik DL (2013) Candidate genes for type 1 diabetes
modulate pancreatic islet inflammation and beta-cell apoptosis.
Diabetes Obes Metab 15(Suppl 3):71–81
9. Ashton MP, Eugster A, Walther D et al (2016) Incomplete immune
response to coxsackie B viruses associates with early autoimmunity
against insulin. Sci Rep 6:32899
10. Domsgen E, Lind K, Kong L et al (2016) An IFIH1 gene polymor-
phism associated with risk for autoimmunity regulates canonical
antiviral defence pathways in coxsackievirus infected human pan-
creatic islets. Sci Rep 6:39378
11. Schulte BM, Gielen PR, Kers-Rebel ED et al (2016) Enterovirus
exposure uniquely discriminates type 1 diabetes patients with a
homozygous from a heterozygous melanoma differentiation-
associated protein 5/interferon induced with helicase C domain 1
A946T genotype. Viral Immunol 29:389–397
12. Oikarinen S, MartiskainenM, Tauriainen S et al (2011) Enterovirus
RNA in blood is linked to the development of type 1 diabetes.
Diabetes 60:276–279
13. Oikarinen S, Tauriainen S, Hober D et al (2014) Virus antibody
survey in different european populations indicates risk association
between coxsackievirus B1 and type 1 diabetes. Diabetes 63:655–
662
14. Hamalainen S, Nurminen N, Ahlfors H et al (2014) Coxsackievirus
B1 reveals strain specific differences in plasmacytoid dendritic cell
mediated immunogenicity. J Med Virol 86:1412–1420
15. Kallionpää H, Elo LL, Laajala E et al (2014) Innate immune activity
is detected prior to seroconversion in children with HLA-conferred
type 1 diabetes susceptibility. Diabetes 63:2402–2414
16. Kupila A, Muona P, Simell T et al (2001) Feasibility of genetic and
immunological prediction of type I diabetes in a population-based
birth cohort. Diabetologia 44:290–297
17. Honkanen H, Oikarinen S, Pakkanen O et al (2013) Human entero-
virus 71 strains in the background population and in hospital pa-
tients in finland. J Clin Virol 56:348–353
18. Piccolo SR, Withers MR, Francis OE, Bild AH, Johnson WE
(2013) Multiplatform single-sample estimates of transcriptional ac-
tivation. Proc Natl Acad Sci U S A 110:17778–17783
19. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and
integrative analysis of large gene lists using DAVID bioinformatics
resources. Nat Protoc 4:44–57
20. Rusinova I, Forster S, Yu S et al (2013) Interferome v2.0: An up-
dated database of annotated interferon-regulated genes. Nucleic
Acids Res 41:D1040–D1046
21. Du P, Kibbe WA, Lin SM (2008) Lumi: a pipeline for processing
illumina microarray. Bioinformatics 24:1547–1548
22. Suomi T, Seyednasrollah F, Jaakkola MK, Faux T, Elo LL (2017)
ROTS: an R package for reproducibility-optimized statistical test-
ing. PLoS Comput Biol 13:e1005562
23. Zhai Y, Franco LM, Atmar RL et al (2015) Host transcriptional
response to influenza and other acute respiratory viral infec-
tions—a prospective cohort study. PLoS Pathog 11:e1004869
24. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG
(2009) The prevalence of enteroviral capsid protein vp1 immuno-
staining in pancreatic islets in human type 1 diabetes. Diabetologia
52:1143–1151
25. Richardson SJ, Leete P, Bone AJ, Foulis AK, Morgan NG (2013)
Expression of the enteroviral capsid protein VP1 in the islet cells of
patients with type 1 diabetes is associated with induction of protein
kinase R and downregulation of mcl-1. Diabetologia 56:185–193
26. Ylipaasto P, Kutlu B, Rasilainen S et al (2005) Global profiling of
coxsackievirus- and cytokine-induced gene expression in human
pancreatic islets. Diabetologia 48:1510–1522
27. Ferreira RC, Guo H, Coulson RM et al (2014) A type I interferon
transcriptional signature precedes autoimmunity in children genet-
ically at risk for type 1 diabetes. Diabetes 63:2538–2550
28. Alidjinou EK, Sane F, Engelmann I, Hober D (2013) Serum-
dependent enhancement of coxsackievirus B4-induced production
of IFNalpha, IL-6 and TNFalpha by peripheral blood mononuclear
cells. J Mol Biol 425:5020–5031
29. HuX, Yu J, Crosby SD, Storch GA (2013)Gene expression profiles
in febrile children with defined viral and bacterial infection. Proc
Natl Acad Sci U S A 110:12792–12797
388 Diabetologia (2018) 61:381–388
